153 related articles for article (PubMed ID: 26057705)
1. Synthesis and quantitative structure-activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
Yang J; Ma M; Wang XD; Jiang XJ; Zhang YY; Yang WQ; Li ZC; Wang XH; Yang B; Ma ML
Eur J Med Chem; 2015 Jun; 99():82-91. PubMed ID: 26057705
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Quantitative Structure-activity Relationships Study for Arylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication.
Min M; Xingjun J; Xueding W; Hao Z; Weiqing Y; Yuanyuan Z; Changrong P; Zicheng L; Jing Y; Quan D; Menglin M
Chem Biol Drug Des; 2016 Sep; 88(3):451-9. PubMed ID: 27085815
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
4. Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs.
Wang P; Naduthambi D; Mosley RT; Niu C; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2011 Aug; 21(15):4642-7. PubMed ID: 21704526
[TBL] [Abstract][Full Text] [Related]
5. Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
Perni RB; Conway SC; Ladner SK; Zaifert K; Otto MJ; King RW
Bioorg Med Chem Lett; 2000 Dec; 10(23):2687-90. PubMed ID: 11128652
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel 5-hydroxy-1H-indole-3-carboxylates with anti-HBV activities based on 3D QSAR studies.
Chai HF; Liang XX; Li L; Zhao CS; Gong P; Liang ZJ; Zhu WL; Jiang HL; Luo C
J Mol Model; 2011 Aug; 17(8):1831-40. PubMed ID: 21053034
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents.
Chen H; Ma YB; Huang XY; Geng CA; Zhao Y; Wang LJ; Guo RH; Liang WJ; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2014 May; 24(10):2353-9. PubMed ID: 24731274
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
[TBL] [Abstract][Full Text] [Related]
12. Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.
Stachulski AV; Pidathala C; Row EC; Sharma R; Berry NG; Lawrenson AS; Moores SL; Iqbal M; Bentley J; Allman SA; Edwards G; Helm A; Hellier J; Korba BE; Semple JE; Rossignol JF
J Med Chem; 2011 Dec; 54(24):8670-80. PubMed ID: 22059983
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
14. Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro.
Delaney WE; Edwards R; Colledge D; Shaw T; Furman P; Painter G; Locarnini S
Antimicrob Agents Chemother; 2002 Sep; 46(9):3057-60. PubMed ID: 12183271
[TBL] [Abstract][Full Text] [Related]
15. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.
Liu C; Dumbre SG; Pannecouque C; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
J Med Chem; 2016 Oct; 59(20):9513-9531. PubMed ID: 27748590
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Luo J; Huang XY; Chen H; Zhou NJ; Zhang XM; Chen JJ
Eur J Med Chem; 2012 Aug; 54():352-65. PubMed ID: 22687441
[TBL] [Abstract][Full Text] [Related]
17. Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.
Zhang Q; Jiang ZY; Luo J; Cheng P; Ma YB; Zhang XM; Zhang FX; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4647-50. PubMed ID: 18644720
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
[TBL] [Abstract][Full Text] [Related]
19. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors.
Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ
Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
